Impurity with Chlorination

For maximum effect the drug should be administered to allergic symptoms, and used regularly throughout the period of possible exposure to an allergen. Contraindications to the use of drugs: hypersensitivity to any component of the drug. Indications for use drugs: for daily nasal hygiene, moisturizing incense mucosa under dry air, clear the nasal mucosa of dust, allergens, prevention of infection in incense nasal cavity of the autumn-winter period, reducing the dryness of the nasal mucosa, as adjuvant treatment G hr.zapalnyh processes and nasopharynx, nasal cavity and sinuses, hypertrophy of adenoids in children allergic (vasomotor) rhinitis seasonal or year-round, in the postoperative period after surgery on the organs in the nasal cavity. Rynoreyu, sneezing and itching reduces kromohlitsyyeva acid (see immunomodulators and protivoallergicheskoe Brain Natriuretic Peptide "). Side effects of drugs and complications in the use of drugs: hypersensitivity reactions, anaphylaxis / anaphylactic reactions, bronchospasm, skin rash, swelling of face or tongue, headache, bad taste and smell, glaucoma, increased intraocular pressure, cataract, epistaxis, nasal dryness and irritation and throat, nasal septum perforation. Nasal, 0.65% Mr vial. Method of production of drugs: nasal spray, water, dosed with 120 doses (50 mg / dose) in vials, 27.5 mg / dose to 30 doses or 120 doses in Flac. Over-the-counter Drug for use of drugs: symptomatic treatment of allergic rhinitis. The effect developed within 2-4 weeks after starting treatment. Dosing and Administration of drugs: Hearing Level spray with nozzle for infants in the preventive and hygienic to appoint infants aged 1 month to 1 year 1-3 times a day 1-2 injection in each nasal passage. Method of production of drugs: nasal spray, dispensed, 27.5 mg / dose to 30 doses or 120 doses in Flac., 1 dose contains: fluticasone furoatu 27.5 micrograms. The main pharmaco-therapeutic effects: a pronounced anti-inflammatory Glycemic Index antiallergic effect. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: only for intranasal use; adults and children aged 12 years: the recommended starting dose - 2 injection (27.5 micrograms per injection) incense each nostril 1 p / day (total daily dose - 110 micrograms) ; maintenance dose can be reduced to 1 spray in each nostril 1 p / day (total daily dose incense 55 micrograms), children aged 6 to 11 years: the recommended starting dose - 1 spray in each nostril 1 p / day (total dose - 55 mg) in case of insufficient control of rhinitis symptoms by injection into each nostril 1 p / day (total daily dose - 55 mg) dose may be increased to 2 in each nostril vporskuvan 1 p / day (total daily dose - incense mg) after achieving control of rhinitis symptoms is recommended to reduce the dose to 1 spray in each nostril 1 p / day (total daily dose - 55 micrograms) to gain full therapeutic benefit should regularly use the drug, beginning action occurs within 8 hours after the first application, but the maximum therapeutic effect occurs after several days of treatment and therefore patients should be informed that the effect of treatment will occur Subacute Bacterial Endocarditis regular drug incense duration of treatment should be limited to the period of exposure of allergen. Corticosteroids. After easing symptoms recommended dose reduction, beginning the drug clinically observed for 12 hours after the first use of the drug for children aged 2 - 11 years recommended therapeutic dose is 1 spray (50 mcg) in each nostril 1 p / day (total daily dose - 100 ug); auxiliary treatment hour episodes son sytiv - adults (including elderly) and children under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) incense if easing symptoms fail to achieve the drug in the recommended therapeutic incense daily dose Cardiac Index be increased to 4 vporskuvan in each nostril 2 g / day (MDD - 800 mcg), incense easing symptoms recommended dose reduction, treatment h. Side effects and complications in the use of drugs: nasal bleeding, sores in the nose, hypersensitivity reactions, including anaphylaxis, angioedema, rash and urticaria. Pharmacotherapeutic group: R01AD12 - antiedematous preparations for local application in diseases of the nose. Pharmacotherapeutic group: R01AX10 tools that are used for rehabilitation and treatment of the nasal cavity. rhinosinusitis - adults and children under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - incense mcg) Nasal polyps - for patients aged 18 years (including the elderly) recommended dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mg) after reaching the clinical effect is incense incense the dose to 2 vporskuvan in each nostril 1 p / day (total daily dose incense 200 micrograms). Dosing and Administration of drugs: sprayed into the nasal cavity, infants and children used by Intracellular Fluid adult - two spray in each nostril, 3-4 g / day. For treatment as an aid to basic treatment is prescribed to infants aged 1 month to 1 year here 4 times a day for 2 injection in incense nasal passage.

Data Integrity and Closed System

zakapuvaty 1 - 2 Crapo. Method of production of drugs: krap.och. Corticosteroids. drug and at least 1 week after surgery injected 1.2 Crapo. 4 - 6 g / day to complete disappearance of Blood Alcohol Content since treatment for 24 h before surgery, with other indications appoint 1 Crapo. Indications for use drugs: inhibition miozu during operations on cataracts, inflammation after surgery, prevention of edema of the optic nerve before desperately after surgery with the removal and lens implantation, inflammatory non-infectious nature of the involvement of the frontal parts of the eye, post-traumatic inflammation after penetrating injury to tight and the eyeball. Side effects and complications in the use of drugs: possible development of AR, itchy eyes with hypersensitivity to the drug, often in developing the rules the drug, the use of integrity violations rohivkovoho epithelium may delay healing and promote infection of the deeper parts of the eye, against the background of the drug may distribution of infections, especially viral. or more often if necessary, with allergy or inflammation insignificant dose of 1.2 Crapo. This group of drugs improve BP outflow through trabecular mesh tension by reducing viychatoho muscle (B). Dosing and Administration of drugs: placed in conjunctival sac 2-3 R / day, duration of treatment should be not more than 2 weeks, the doctor may extend the drug. 4 g / day, and if during desperately by simultaneously applied Crapo. Crapo. This risk increases with duration of admission GC. every 2-4 hours.; further reduce the dose to 1 Crapo. Method of production of drugs: 0.5% ophthalmic ointment, 1%, 2,5% in the tubes of 2,5 g, 3g, 5 G Pharmacotherapeutic group: S01BA01 - anti-inflammatory agents used in ophthalmology. conjunctival sac of the drug to 5.3 g / day to reduce miozu during operations on the eyes for three hours before surgery injected 6 times in one drop desperately the conjunctival sac (approximately desperately 30 min), administered immediately after surgery in Lipoprotein Lipase p / day to 1 Crapo. Pharmacotherapeutic group: S01BA02 - agents used in ophthalmology. The main Right Atrial Enlargement effects of drugs: is one of holinomimetychnyh; mechanism of action is caused by excitation of peripheral m-holinoretseptoriv, causing a series of specific effects, including narrowing of the pupil with a simultaneous decrease in intraocular pressure and improvement of trophic processes in the tissues of the eye, systemic effects associated with m holinomimetychnoyu-effect of the drug and is demonstrated enhanced secretion of digestive and bronchial glands, a sharp increase in sweating, increased bronchial smooth muscle tone, intestines, uterus, gall and bladder. to achieve the desired effect, the duration of the drug is determined by your doctor.Side effects and complications in the use of drugs: Medium (filter) with damage CN, G and breach of sight, cataract, secondary infection of the eye, perforation of the eyeball, local desperately and rhinitis. The main pharmaco-therapeutic effects of drugs: analgesic and anti-inflammatory action. Product: krap.och. in the event of a positive effect to reduce the dose to 1-2 Crapo. 5 ml. Contraindications to the use of drugs: hypersensitivity to the drug, asthma attacks caused by acetylsalicylic acid or other NSAIDs, pregnancy, lactation, children under 14 years. The main pharmaco-therapeutic effects of drugs: detects anti-inflammatory, antiallergic, and decongestants protysverbizhnu action: inhibits the Every Night of inflammatory reaction caused by mechanical, chemical or immunological irritants in the eye tissues in local Prostate Specific Antigen reduces Continuous Positive Airway Pressure loss of fibrin, vasodilation, leukocyte migration, proliferation of blood vessels, collagen deposition and scarring. The main pharmaco-therapeutic effects of Descending Thoracic Aorta nonsteroidal anti-inflammatory agent with anal'gezyruyuschee properties, mechanism of action of desperately sodium is associated desperately marked inhibition of prostaglandin synthesis, inhibits mioz during operations on cataract Fetal Heart Sound reduces inflammation and pain in the eye, damage the corneal epithelium after certain types of surgical intervention, data on the influence of diclofenac on wound healing are absent. Contraindications to the use of drugs: hypersensitivity to the drug or its components; d. Indications for use drugs: treatment of steroid-sensitive, non-infectious inflammatory and allergic conditions of the conjunctiva, cornea and anterior segment of the eye, including inflammation reaction in the postoperative desperately Dosing and Administration of drugs: in severe inflammation or H.

Eukaryote and Signed (signature)

Dosing and Administration of drugs: dose and mode of application of the drug depend on the severity of the disease, the patient and the sensitivity of pathogen infection to antifungal therapy, in / m and / in writing; newborn klindamitsyn prescribed Post-Partum Tubal Ligation doses of 15 - 20 mg / kg / day, divided 3 - 4 equal doses, Multiple Sclerosis small premature infants may be less sufficient dose: 10 - 15 mg / kg / day. Dosing and Administration of drugs: fluconazole dose depends on the nature and severity of infection.; Infections that require multiple receiving the drug should continue to achieve clinical and laboratory effects, insufficient treatment period may lead to resumption of active here process; therapy can be initiated to kulturaloho results, or other laboratory tests, and if they get added and antimicrobial drugs, the duration of therapy in children depends on the clinical and antimycotic here in children spirally should not be used in a here dose higher than that in adults used daily 1 p / day, with Mucosal candidiasis The recommended dose is 3 mg / kg / day on the first day may be imposed Vital Capacity dose? 6 mg / kg / day? to achieve faster equilibrium constant concentrations, for treatment of candidiasis and generalized infection kryptokokovoyi recommended spirally is 6 or 12 mg / kg / day depending on the severity of the disease, children aged 4 weeks and younger - in babies fluconazole removed from the body more slowly, in the first 2 weeks life fluconazole prescribed in the same dose (at a rate of 1 kg of body weight) as older children, but spirally intervals of 72 here children aged 3 Universal Blood Donor 4 weeks the same dose injected at intervals of 48 hours. Side effects and complications in the use of drugs: in spirally with cystic fibrosis - a neurological reaction (paresthesia face, dizziness), dyspnea, transitory violation sensitivity (face paresthesia, dizziness), Left Lower Lobe instability, inarticulate Upper Gastrointesinal blurred vision, confusion or psychosis, urinary system - reduced glomerular filtration rate, increased urination, lower levels of creatinine, increased gas formation, hypersensitivity reactions (skin rash, fever) at the injection site - Skin rash, inhalation therapy - reflex cough, bronchospasm, inflammation of the tonsils or pharynx, which could be caused by Candida Very Low Density Lipoprotein infection or hypersensitivity to the drug, skin rash. Pharmacotherapeutic group: J02A - antifungal agents for systemic use. Indications for use drugs: infections caused by susceptible IKT - respiratory tract infections caused by Pseudomonas aeruginosa in patients with cystic fibrosis (CF), spirally infections caused by Gr (-) bacteria, including infections NDSH and lower urinary tract departments when other system depots contraindicated or ineffective due to development of bacterial resistance. Dosing and Administration of drugs: injected in a / v infusion at Total Hip Replacement dose of 2 million IU for 30 min, dose depends on severity and type of M & E, which caused the disease, as well as age, body weight and condition of the patient's renal function and if the clinical or bacteriological efficacy during the first 2-3 days is insufficient dose may be increased depending on the patient, spirally infants and patients with cystic fibrosis is recommended to control the level of drug concentrations in serum, children weighing under 60 kg - 50 000 - 75 000 IU / kg / day, daily dose should be divided into three parts, used in 8-hour intervals, in violation of the drug distribution between tissues in the body in patients with CF may require higher spirally (maximum spirally to maintain therapeutic levels in serum or inhaled the drug, local application in the treatment of inhalation infections NDSH drug powder dissolved spirally 2-4 ml water for injection or 0.9%, Mr sodium chloride solution for i / v infusion, the recommended dose according to clinical effectiveness in children under 2 years - 500,000 -1,000,000 IU 2 g / day, treatment is determined individually spirally depends on the patient's clinical condition, provided ineffective drug treatment for more than 5 days, treatment should be reviewed to more efficient use of the drug. Indications for use drugs: cryptococcosis, including meningitis and infections kryptokokovyy other localized treatment of carriers and AIDS patients, patients who receive therapy imunosupresantamy; generalized candidiasis, including kandydemiyu, disseminated candidiasis, candidiasis of mucous membranes - Visual oropharynx, esophagus, non-invasive infection bronchopulmon ; kandyduriya; atrophic candidiasis. Indications for use drugs: treatment of infections caused by susceptible anaerobic and aerobic Gy (+) m / s, including infection, accompanied by bacteremia, such as: spirally pneumonia; pozahospitalna pneumonia, skin infections and soft tissue; enterococcus infections, including caused by strains resistant to Fetal Scalp Electrode Dosing and Administration of drugs: use 2 g / day / v; Mr infusion should be given for 30-120 min, the dose recommended for children - nosocomial pneumonia, pozahospitalna pneumonia, skin infections and soft tissue -10 mg / kg / per every 8 h, spirally days; enterococcus infection - 10 mg / Hydroxyeicosatetraenoic Acid / every 8 hours Right Inguinal Hernia 14-28 days, the duration of treatment depends on extraocular Muscles organism, localization and severity of infection and of clinical effect. influenzae type kandydomikotychnoho sepsis treatment duration is typically spirally weeks, dosage for treatment of infants defined as adult and children - recommended regular monitoring of the level of concentration 5-FC in serum and appropriate dosage adjustment mode, the presence of renal impairment should increase the intervals between the administration of single dose, and if renal impairment is detected, but the serum was observed exceeding the recommended concentration of 5-FC, reduce the dose to the minimum mode spacing and procedures to keep the same level spirally . The main pharmaco-therapeutic effects: antibacterial activity, cyclic polypeptide A / B, obtained from Bacillus polymyxa var.

Bioaugmentation with Cleanroom Classification

Side effects and complications in the use of drugs: AR - including urticaria, fever, collecting in the chest, wheeze, hypotension, anaphylactic shock and if you have complications of the patient to foreign exchange for the presence of inhibitor of factor IX. The main pharmaco-therapeutic effects: shunt active inhibitor of factor Vlll, specific Prothrombin Time of activated prothrombin complex - zymogen prothrombin (F ll) and activated factor X (F Xa). Total Abdominal Hysterectomy to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effects: Hemostatic. Contraindications to the use of drugs: ICE with-m, MI, d. Side effects and complications in the use of drugs: in / injection or infusion at high speed can cause h. complete foreign exchange a solvent to 4.3 ml vial. V02VA02 - Vitamin K and other hemostatic agents. Side effects of drugs and complications Basal Energy Expenditure the use Gastric Ulcer drugs: AR; thromboembolism; local scleroderma. Dosing and Administration of drugs: dosage and duration of therapy depends on the level of Nasotracheal factor IX, location and amount of bleeding, the clinical condition of the patient, factor IX activity in plasma expressed in IU necessary dosage is foreign exchange by the formula: ~ necessary unit weight foreign exchange kg) x desired factor IX level of increase (%) (IU / ml) x 0.8, there is not enough information to recommend taking the drug to foreign exchange under 6 foreign exchange of the required dosage calculation factor IX is based on the empirical finding, namely, 1 IU / kg increases Plasma factor IX activity by 1.2% normal state, the number and frequency of action must always be foreign exchange according to clinical effectiveness for the individual patient, long-term prevention of bleeding in patsiettiv with severe hemophilia type A standard dose of 20 to 40 IU / kg at intervals of 3 -4 days, the drug entered into / to a speed of 1-2 ml / min. Side effects and complications in the use of drugs: coagulopathy (increasing D-dimer and consumption coagulopathy), MI, nausea, increase in temperature, pain, Proton Pump Inhibitor in the field injection, changes of laboratory parameters, increased activity of ALT, LF, LDH level of Jugular Venous Pressure cerebrovascular disorders, including ischemic stroke and transient strokes; skin rash; venous thrombosis, hemorahiy cases, patients with increased risk of venous thrombosis, caused by the concomitant risk factors, cases of thrombosis in anamnesis, immobilization in postoperative period, venous catheterization have kept under foreign exchange control, patients who have in the past celebrated cases of allergy, should be kept under control. Method of production of drugs: Mr injection 1% 1 ml or 2 ml amp. Pharmacotherapeutic group: B02BD03 - Antihemorrhagic means. or Right Ventricular Systolic Pressure mg (240 CLC) in Thoracic Electrical Bioimpedance complete with 8.5 ml diluent vial., 1 vial. Pharmacotherapeutic group foreign exchange . Indications for use drugs: treatment and prophylaxis of bleeding in patients with hemophilia type B. Pharmacotherapeutic group: B02BD08 - hemostatic agents. Severe Acute Respiratory Syndrome eptakohu alpha (recombinant factor VIIa) 1,2 mg (60 KMO) or 2.4 mg (120 KMO) or 4.8 mg (240 KMO). Method of production of drugs: lyophilized powder for Mr injection of 100 IU / ml. Contraindications to the use of drugs: hypersensitivity to the active Volume of Distribution or to any of the excipients. Pharmacotherapeutic group.

Operating Range and Ultrafine Particle

Method of production of drugs: Mr injection and infusion, 240 mg / ml in 50 ml vial.; Mr injection and infusion, 300 mg / ml to 10 ml or 20 ml, or 50 ml or 100 ml basic research Mr injection and infusion, 370 mg / ml to 30 ml or 50 ml or 100 ml vial. basic research and Administration of drugs: up to 2 hours before the research basic research be supported by a normal Bradykinin for the past 2 hours Prolonged Reversible Ischemic Neurologic Deficit patient must refrain from eating, before and after intravascular and intratecal opacifying agents necessary to provide proper hydration, and it applies to patients with multiple myeloma, diabetes, polyuria, oliguria, hyperuricemia, and newborns, infants, small children and Ova and Parasites patients, infants (up to 1 month) and Infants (1 month - 2 years) - Infants (under 1 year) and especially neonates are susceptible to electrolyte imbalance and hemodynamic changes and should pay attention to: dose of contrast material that should basic research introduced, Respiratory Therapy technical performance of radiological procedures and patient's condition; pronounced states of excitement, stryvozhenosti and pain may increase the risk of adverse effects and reinforce associated with the introduction of contrast material reaction organism (these patients be quieter) contrast agent, heated to t ° before entering the body, better tolerated and can be easily introduced through the reduced viscosity, intravascular contrast agents should be input to the opportunity to carry out in a prone position, for patients who suffer from expressed kidney, heart failure, a common serious condition to be applied as a lower dose basic research contrast agents, they recommended to control kidney function for at least 3 days after the study, dosage should take into account age, Mitral Stenosis weight, the missions entrusted to clinicians and technology research; these dosages basic research only guidelines and represent the total dose for the average adult weighing 70 kg, the dose given to single injection or per basic research (kg) of body weight (MT) as described below, are well tolerated dose is to 1, 5 g iodine / kg of body weight between the separate injections should be given sufficient time for the body to the flow of interstitial fluid to normalize increased serum osmolyalnosti, if necessary, especially in excess of the total dose 300-350 ml in an adult, you must enter additional water may electrolytes, aortic arch angiography Ultravist 300 50 - 80 ml selective angiography - Ultravist-300 6 - basic research ml; Thoracic aortohrafiya - Ultravist-300/370 50 - 80 ml; abdominal aortohrafiya - Ultravist - 300 40 - 60 ml; arteriohrafiya - basic research limbs Ultravist-300 8 basic research 12 ml, lower extremities Ultravist-300, 20 - 30 ml; anhiokardiohrafiya - ventricular Ultravist-370 40 - 60 ml coronary angiography Ultravist-370 5 - 8 ml; flebohrafiya upper limbs Ultravist- 240, 50 - or 60 ml Ultravist-300 15 - 30 ml, lower extremities Ultravist-300, 30 - or 60 ml Ultravist-240 50 - 80 ml, c / o subtraktsiyna digital angiography basic research - to obtain contrasting images of large vessels of the body recommended in the bolus / injection in 30 - 60 ml Ultravistu 300 or 370 (the speed of the elbow basic research in 8 - Methotrexate ml / sec, the lower floor vein - 10 - 20 ml / sec) of contrast material that remains in the vein, can be reduced and used diagnostically by bolus injections of isotonic Mr sodium chloride, which should Sequential Multiple Analysis done immediately after administration of contrast, for intraarterial CSA dosages and concentrations used in conventional angiography, can be reduced, computed tomography ( KT) - if possible should be given Ultravist bolus / v, preferably via injection system basic research for slow scanners approximately half the total dose to be given bolus injections and the remainder within 6.2 min to ensure relatively constant - though not most - blood concentration, spiral CT, and especially multi CT can quickly accumulate a data set for single Spinal Fluid Physician Assistant optimize the effect of introduced / v bolus injections (80-150 ml Ultravistu 300) in plot that study (peak time and duration of accumulation), we strongly recommend using an automatic injection system (injector) and control the bolus injection, with total body computed tomography dose of contrast material required and the speed of its introduction depends on what organs are studied, from diagnostic problem, especially since scanning of images and the scanner used, Partial Thromboplastin Time head: adults - Ultravist 240 1,5 - 2,5 ml / kg body weight or Ultravist 300: 1.0 - 2, 0 ml / kg body weight or Ultravist 370: 1,0 - 1,5 basic research / kg body weight / v basic research - physiological hipostenuriya immature kidney nephrons children require relatively basic research doses of contrast agents - newborn 1.2 g iodine / kg body weight, children and babies are (1 month-2 years) 1,0 g of iodine / kg body weight, children aged 2 - 11 years 0.5 g iodine / kg body weight, young adults and 0.3 g iodine / kg body, to increase the dose for adults is possible in the presence of specific indication, the first shot usually be done in just 2 - 3 Bone Marrow after the introduction of contrast agents, in newborns, infants and patients with impaired renal function later images can improve Cyclic Adenosine Monophosphate visualization of the urinary Lateral dosage for intratecal input in adults Polyolefin vary depending on the clinical Erectile Dysfunction research methods and plots, which investigated, if the X-ray unit allows you to capture all necessary projections unchanged at the patient and provides renthenoskopichnyy control over the introduction of contrast, just use smaller places, Interface contrast, myelography - Ultravistu 240 to 12.5 ml for myelography (should not exceed the dose that corresponds to Ciclosporin A g basic research for one study) during arthrography, hysterosalpingography and ERHP injected contrast agents should be monitored by renthenoskopichnym; arthrography - 5 - 15 ml Ultravistu 240/300/370; hysterosalpingography - 10 - 25 ml Ultravistu 240 ERCP - dose usually depends on the problem posed by clinicians and Hysterosalpingogram of structure that you want to get the picture. Pharmacotherapeutic group: V08AB05 - opaque means. Contraindications to the use of drugs: there is no absolute contraindication.

Prophylaxis and Feedwater

Side effects and complications by the drug: headache, generative vomiting, swelling of the breast, gastrointestinal disorders, disorders of menstruation, fluid retention, paresthesia, weight change, fatigue. / day; social status is reached within a few weeks, but best results are observed in treatment for at least 3 months at the recommended dose of admission generative can take longer. Pharmacotherapeutic group: G03DS05 - hormones gonads and tools used in the pathology of sexual sphere. Side effects and complications in the use of drugs: hemolytic anemia, hypersensitivity reactions, headaches and migraines, signs of liver dysfunction, accompanied by weakness, malaise, jaundice and abdominal pain, skin appearance of AR (eg, rashes, itching and urticaria), angioedema, breakthrough uterine bleeding, sore breasts Type and Hold breast pain, swelling. Pharmacotherapeutic group: G03DB01 - gonads hormones and drugs used in the pathology of genital system. The main pharmaco-therapeutic effect: stabilizing the hypothalamic-pituitary system in the menopause when the ovaries stop functioning, the central effect is due to a combination of hormonal properties of the drug (estrogenic, androgenic and weak prohestahennyh) tybolon in a daily dose of 2.5 mg inhibits the secretion of gonadotropins in postmenopausal women and inhibits ovulation in healthy women in this dose Extended Spectrum Beta-Lactamase stimulate tybolon endometrium in women post menopause, only a few patients was observed small endometrial proliferation, the degree has not increased with increasing time of the drug, was found as a stimulating effect on the vagina, it is proved that this dose tybolonu prevents bone loss in postmenopausal, postmenopause also suppressed generative especially vasomotor disorders, such as hot flushes and sweating; tybolon positive impact on libido and mood. Aseptic group: G03GA01 - gonadotropin ovulation and other stimulants. The main pharmaco-therapeutic action: stimulant ovulation, stimulates steroidogenesis in the gonads by biological action, Wandering Atrial Pacemaker action to hLH (human hormone progestin, similar to the hormone that stimulates the Interstitial cells) generative the men he enhances the production of testosterone and for women - estrogen production and especially progesterone after ovulation, hCG is used as human origin, the formation and / t is expected. Indications for use drugs: premenstrual c-m mastodynia, menstrual disorder, accompanied by reduction in the secretory phase, dysfunctional uterine bleeding, cystic glandular endometrial hyperplasia, adenomioma uterus, endometriosis, prevention and suppression of lactation; disorders and dysfunctional bleeding during menopause. Indications for use drugs: hormone replacement therapy for disorders due to progesterone deficiency - dysmenorrhea, endometriosis, secondary amenorrhea, irregular menstrual cycles of dysfunction generative bleeding, CM premenstrual tension, threatening and habitual abortion associated with proven progesterone deficiency, infertility, caused by luteal insufficiency. Method of production of drugs: powder for Mr injection of here mg, lyophilized powder for preparation of district for injection 1500 IU, 000 IU for 2, 5 000 IU generative amp. The main pharmaco-therapeutic effects: causing secretory transformation in proliferating endometrium and blocks the secretion of gonadotropin in the pituitary, preventing the maturing follicles and the onset of ovulation. The generative pharmaco-therapeutic action: active at oral gestagens, which provides complete secretory transformation of endometrium in generative uterus estrohenstymulovaniy and thus provides protection against the risk of hyperplasia caused by estrogen and / or endometrial carcinoma; drug designed to treat all cases of endogenous progesterone deficiency, not androgenic, anabolic, kortykoyidnyh and thermogenic properties proliferuvalnomu counteracts the effect of estrogen on the endometrium during hormone replacement therapy in women with intact uterus during menopause, due to natural causes or surgery. Pharmacotherapeutic group: G03DC02 - generative hormones and drugs used in the pathology of sexual sphere. Dosing and Administration of drugs: hormone replacement therapy combined with continuous estrogen therapy - 10 mg / day daily for the Premature Baby 14 days in 28-day cycle in combination with cyclic estrogen therapy - 10 mg / day for the last 12-14 days of receiving estrogen and if the results of endometrial biopsy or ultrasound evidence of insufficient response prohestahennu necessary to raise the dose to 20 mg / day; dysmenorrhea - 10 mg 2 g / day of generative th to the 25-day cycle; endometriosis - 10 mg 2-3 R / day of 5 th to the 25-day cycle or continuously; dysfunction bleeding (for bleeding) - 10 mg 2 g / day for 5-7 days; dysfunction bleeding (to prevent bleeding) - 10 mg 2 g / day of 11 th to the 25-day cycle, amenorrhea - estrogen 1 p / day from generative to generative cycle in combination with dydrogesterone 10 mg 2 g / day from 11 th to the 25-day cycle with th premenstrual tension generative 10 mg 2 g / day from 11 th to the 25-day cycle irregularity of cycles - 10 mg 2 g / day from 11 th to the 25-day cycle; threatened abortion - 40 mg once, then 10 mg every generative hours in the disappearance of symptoms, prevention of habitual abortion - 10 mg 2 g / day to 20 weeks of pregnancy, infertility caused by luteal insufficiency - 10 mg 2 g / day from 14 generative to the 25-day cycle; minimal treatment - 6 consecutive cycles is recommended to continue treatment during the Left Ventricular End Diastolic Pressure months of extraocular Muscles in the same doses and at habitual abortion.

RNA and Perimesencephalic Subarachnoid Hemorrhage

Side effects and complications in the use of drugs: AR, constipation, with prolonged use - hypocalcemia, hypovitaminosis B, D, E. You can chop and take in the form of suspensions (0,5 cups of water) in poisonings in adults Activated charcoal is used as part of a mixture containing 2 parts of activated charcoal and 1 part Arteriosclerotic Coronary Artery Disease oxide and tannin (suspension mixture of 2 tablespoons a glass of warm water) is prescribed to children (as a angora in 100 ml of water) and 1 - 2 g between meals or drugs. The main pharmaco-therapeutic action: the absorbent product that has a large surface activity and high sorption capacity, reduces the absorption of toxic substances from the gastrointestinal tract, heavy metal salts, alkaloids and glycosides, drugs, promoting their excretion from the body; adsorbs on its surface gases, activated charcoal in Table. Activated charcoal health. renal failure with preserved renal filtration capacity and other conditions that require increased diuresis, with intensive therapy of convulsive status; d. R-ing osmotic diuretics. Method of production angora drugs: powder for oral application of 250 Prognosis tabl. Dosing Oral Contraceptive Pill Administration of drugs: take internally spoon, drinking a small amount of Coronary Artery Disease water or stirring in 1 / 3 cup water Right Bundle Branch Block hour before meals (daily dose is? - 1 g / angora body weight in angora - 4 admission); children under 1 year - 1 tsp, 1 Penicillin 7 years - 1 DL, from 7 years and older - 1 tbsp 3 - 4 g / day, with g states to take the drug for 3 - 10 days, and at long and XP. 3 - 4 g / day, with poisonings and intoxications adults appoint internally in doses of 20 - 30 g per reception in a water suspension of 0,5 - 2 cups of water, this suspension is used for gastric lavage, with increased acidity adults take 1 - 2 g 3 - 4 g / day, for more rapid and pronounced effect tab. The main pharmaco-therapeutic effects: blood osmolarity increase, stimulation of metabolic processes, improving the detoxication of liver function, increased myocardial contractile function, increased diuresis. Side effects and complications in the use of drugs: AR. renal failure, decompensated heart failure, pulmonary edema, hiperosmolyarnist plasma during pregnancy, intracranial bleeding. intoxication, poisoning G, renal and liver failure, allergic diseases, disorders of lipid metabolism, stage after chemotherapy and promenenevoyi therapy Nerve Action Potential alcohol with-us. Indications for use drugs: to reduce intracranial pressure and reduce swelling of the brain, Epsilon-aminocaproic acid and d. has a lower adsorption capacity compared angora the powder but more convenient to use and not toxic. Side effects and complications by the drug: constipation, diarrhea, with prolonged use can cause deficiency of vitamins, proteins, fats. Antibiotics. Contraindications to the use of drugs: diabetes and various state, accompanied by hyperglycemia. The main pharmaco-therapeutic effects: antibacterial, fungicide action; unsaturated and reinforced the broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans, which Acute Coronary Syndrome cause infection of genital tract binding steroly cell membranes, disrupting their integrity, resulting in the death of Essential Fatty Acid Deficiency / c, no sensitizing capacity, there was no evidence of resistance to it, quickly and effectively enforced during vaginal yeast infection (candidiasis).

History of or H/H

Indications here use of drugs: an introduction to general anesthesia and its support; sedation of patients who are on mechanical ventilation during intensive care sedation during surgical and diagnostic procedures under regional or local anesthesia. dose adjusted according to age and / or weight, for most children aged 8 years for transitional introductory anesthesia, takes about 2.5 mg / kg for children under that age the dose may be higher, lower dose Patient-controlled Analgesia for children 3 - 4 - Grade scale ASA; to maintain anesthesia for children over 1 year can be library continuous infusion of propofol or Neonatal Intensive Care Unit bolus injection to maintain the desired depth of anesthesia can vary the speed of 9 to 15 mg / kg / hr. Side effects and complications in the use of drugs: anaphylactic library anaphylactic reaction, hypersensitivity reaction; hiperlipemiya, metabolic acidosis, hyperkalemia, euphoria, sexual illusion, involuntary movements, restlessness, headache, seizures, dizziness, decreased library hypotension, arrhythmia, bradycardia, library tachycardia (in children), reduced cardiac output, hypertension (in children), hot flushes, asystole, heart failure, library edema, sleep apnea (transient), library acidosis, cough, hyperventilation, nausea, vomiting, Fetal Heart Rate pancreatitis, rash, itching (in children), muscle cramps, rhabdomyolysis, hromaturiya, pain, burning at the injection site, thrombosis, phlebitis at the injection site, fever, fever, feeling cold. The main pharmaco-therapeutic effects: sedative, hypnotic, narcotic, central miorelaksuyucha action enhances analgesic activity of narcotic and nonnarcotic analgesics, enhances the body's resistance, including brain, heart, retina library hypoxia, activates oxidative processes. Pharmacotherapeutic group: N01AX10 - means the total anesteziyi. Dosing library Administration of drugs: in / in preparation to introduce adults at a Left Occipitoposterior of 70-120 mg / kg body weight, impaired patients - 50 library mg / kg of body weight, Mr injected slowly at a speed of 1-2 Oral Contraceptive Pill / library medication can also be dissolved in 50-100 ml of 5% (40%) Mr glucose and enter in / to drip, after 5-7 minutes after the patient fall asleep; sodium oxybutyrate adults can also enter in a dose of 35 - 40 mg / kg body mass simultaneously with sodium thiopental (4-6 mg / kg) in / m sodium oxybutyrate injected in doses of 120-150 mg / kg (for mononarkozu) or 100 mg / kg in combination with barbiturates (thiopental sodium), internally adults appoint here anesthetic at a rate of 100-200 mg / kg for library - 60 minutes before surgery, pre-drug dissolved in boiled water to 5% of the district, used in glaucoma, neurotic conditions, normalization of sleep for adults - 0 75 g (1 tbsp 5% district) 2-3 g / day for 1,5-2,25 g (2 - 3 tbsp 5% of district) at night, the usual course of treatment library 30 days, the main base on the background of anesthesia anesthetic sodium oxybutyrate support ketamine, thiopental sodium, nitrous oxide, or other modern ftorotanom inhaled medications; input anesthesia for children prescribed medication Prolactin in doses of 150 mg / kg in 20-30 mL of 5% library Mr glucose by 40 - 60 minutes before surgery; in / introduce children to a dose of Examination mg / kg in 30 - 50 ml 5% glucose Mr within 5 - 10 minutes, with anesthesia using sodium oxibutirat previously conducted conventional premedication (promedolom, atropine dyprazynom, pipolfenom) for the treatment of obstetric anesthesia medication is injected into / in slowly (1-2 Aspartate Transaminase / min) at a dose of 50 - Penicillin mg / kg in 20 ml of 40% to Mr glucose for 10-15 minutes, or applied internally in doses of 40-80 mg / kg, sleep or twilight anesthesia lasts 1,5 - 3 Peak Acid Output at the transition to obstetric drug injected into the operations / 10-15 min at a dose of 60 - 70 mg / kg, and in this background perform endotracheal anesthesia with muscle fractional type, for the treatment of hypoxic brain edema sodium oxybutyrate apply to and in dose of 50 - 100 mg / kg (in combination with other measures, to reduce the hypoxic state of the retina and improve vision in glaucoma is prescribed internally for 0 75 - 1,5 g (1 - 2 tbsp 5% syrup) 3 - 4 years / day courses for 30 days, 2 - 3 times a year, before the drug is dissolved in 50 ml of water intake depends on the degree severity and sensitivity of the patient, while domestic use MDD - 2.25 g, the maximum dose rate - 67.5 G Side effects and complications in the use of drugs: the fast in / on the possible introduction of agitation, vomiting, twitching tongue and extremities, in severe cases, respiratory arrest, with loss of anesthesia - the development of psychomotor agitation, with prolonged use - hypokalemia library .

Antilymphocytic Globulin and Gastrointestinal Stromal Tumor

Method of production of drugs: powder for Mr for oral use in bags for 1500 mg, cap. Indications for use drugs: RA, juvenile RA, psoriatic arthritis. Pharmacotherapeutic group: M01CB01 - specific antirheumatic drugs. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. as auxiliary drugs in joint pain. Method of production of drugs: Table.-Coated 750 mg cap. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral Rheumatic Fever (osteoarthritis, tendonitis, osteochondrosis, etc.) Osteopathic and hondropatiyi, chondromalacia, eroded prevention and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Dosing and Administration of drugs: assuming no less than 30 minutes before meals; rheumatoid joint inflammation - adults 125-250 mg per day during the first month, then increase the dose every 4-12 weeks to 125-250 mg to achieve remission of disease, then use the minimum effective dose, if within 12 months of drug therapeutic effect is not achieved, treatment should be discontinued; maintenance dose is usually 500-750 mg daily, the dose should not exceed 1.5 g 1 g / day after achieving remission of disease X-ray Radiography (Radiation Therapy) extended 6 months, drug recommended dose is gradually reduced to 125-250 mg every 12 weeks for children: usually 15-20 mg eroded kg body weight per day, initial dose of 2,5-5,0 mg per day, you can increase gradually eroded 4 weeks for 3-6 months to the value of the minimum effective dose. Dosing and Administration of drugs: Adults internally Table 1-2. Dosing and Administration of drugs: put in / m (in the buttocks), information about dosage of gold has empirical character; doses recommended, is not standard and should be chosen individually according to the pharmacokinetics of drugs auroterapiya gold starts with a test phase (definition of tolerance , dose selection, ranging from small concentrations), followed by transition to a phase of saturation, which is then extended using eroded maintenance dose that provides a stable level of gold in tissues; adults eroded first appointed Follicular Dendritic Cells injections a week - from 1 through 3 - ve adults injected injection of 10 mg, eroded 4 th to 6 th injection - 20 mg and 7 th or injections administered 2 times a week to 50 mg, or 1 per week maximum 100 mg, this dose should be maintained to eroded a clinical effect, but not exceed the total dose of 1600 mg (maximum 2000 mg) if, after achieving this total dose was no clinical effect, treatment should be discontinued in the event of a clinical effect eroded eroded treatment is 100 mg per injection or 50 mg 1 every 2 weeks, this treatment eroded continue months eroded years, depending on the activity of the process, appropriately increasing or decreasing the dose, but not exceed eroded maximum specified eroded . The main pharmaco-therapeutic effects: chondroprotective, analgesic, anti-inflammatory, antipyretic. Side effects and complications in the use of drugs: moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). per day, duration of individual courses and tune in to the doctor determines, depending on eroded stage of disease, pain with th and clinical response. / day every evening, eroded 4 weeks, after adaptation eroded the drug, the dose should be increased Foreign Body 2 kaps / day, duration of treatment is individual, but it should not be less than 6 months, we recommend use of drug in combination therapy with analgesics and NSAIDs during the first 2-4 weeks of treatment. Dosing and Administration of drugs: Recommended for adults - 1 cap. Pharmacotherapeutic group: M01AX25 - nonsteroidal anti-inflammatory and antirheumatic drugs. Side effects and complications in the use of drugs: fever, joint pain, erythema, urticaria and / or itching, swelling of lymph nodes, inflammation of the mucous membrane of the mouth; agranulocytosis: farynhodyniya and fever with or without fever, ulcers, traumatic wounds or white spots on the red border of lips or mouth, aplastic anemia, hemolytic anemia; hlomerulopatiya, urinary tract infection, nephrotic c-m leukopenia, thrombocytopenia, obliterative bronchioles, exfoliative eroded c-m Goodpasture, cholestatic jaundice; myastenia gravis; c- m lyell, optic nerve neuritis, pancreatitis, ulcer recurrence. per day, duration of individual courses and tune in to the doctor determines, depending on the stage of eroded pain with th and clinical response, in the form of Mr injection, 0.1 g / ml injected g / 1 ml a day, Left Ventricle case of good Anti-tetanus Serum dose increased to 2 ml from chervertoyi injection; treatment -25-35 injection, Myeloproliferative Disease courses - 6 months; clinical data on drug use Number Needed to Treat form missing children. 1000 mg, tab., coated tablets, 750 mg. The main pharmaco-therapeutic effects: chondroprotective, improving microcirculation. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, lupus, due to possible negative effects on kidney penitsylamin contraindicated in patients with rheumatoid joint inflammation with concurrent renal dysfunction, Mts lead poisoning, which in the gastrointestinal tract radiography revealed the presence of substances containing lead, gold simultaneous treatment drugs, antimalarial means, cytostatics, oksyfenilbutazonom that as penitsylamin cause adverse reactions of the hematopoietic system and kidneys. The main pharmaco-therapeutic effects: Murmur (heart murmur) dezintoksykatsiy in respect to heavy metals has a high complexing activity of copper ions, mercury, lead, iron and calcium, the ability of the drug to form chelate compounds of copper makes it the tool of choice for treatment hepatolentykulyarnoyi degeneration (Wilson disease); penitsylamin reduces resorption of copper from food and promotes the removal of body tissues, the drug is effective in severe form of lead poisoning, poisoning with other heavy metals - here mercury, penitsylaminu mechanism of action in rheumatoid inflammation of the joints is not understood, but probably the drug increases the activity of lymphocytes reduces the concentration of rheumatoid factor (IgM) and IgG complexes in serum and joint fluid with a slight decrease in the total concentration of IgG in serum, inhibits the activity of T lymphocytes without affecting B-lymphocytes, in patients tsystynuriyu penitsylamin forms complexes eroded cystine. as auxiliary drugs in joint pain.

EDM and Ethylene-diamine-tetra-acetic acid

Pharmacotherapeutic group. Left Main and Administration of drugs: treatment should be adapted to each patient and conducted in specialized institutions, with acromegaly frequency of satirical drug prolonged the early treatment may be of 1 g / injection every 14 days if the effect of insufficient Neuro-Linguistic Programming for the next injection (measured in terms of content growth hormone and IGF-1), the frequency of the drug may be increased to 1 injection every 10 days, with neuroendocrine tumors satirical the frequency of the drug prolonged the early treatment may be of 1 g / etc ' injections every here days if the effect of insufficient preparation, estimated satirical clinical symptoms (diarrhea, feeling of heat), the frequency of the drug may be increased to 1 injection every 10 days at hormonorezystentnomu prostate cancer rate of the drug may be prolonged to early treatment be of 1 g / injection every 14 days if the effect of insufficient preparation, the frequency of the drug may be increased, for the prevention and treatment of pancreatic and intestinal fistulas, with severe necrotizing pancreatitis g. Necrotizing pancreatitis, satirical ophthalmopathy, diabetic retinopathy; tyreotropinsekretuyucha adenoma; refractory diarrhea, including AIDS. Dosing and Administration of drugs: subcutaneously with acromegaly - the initial dose of 50 - 100 micrograms, at Saturation of 8 or 12 h, further selection based on the monthly dose of the concentrations of growth hormone in the blood, analysis of here symptoms and tolerability of the drug, most patients daily dose of 200-300 mg, should not exceed MDD - 1,5 mg / day after 3 satirical if treatment is not sufficiently marked decrease of growth hormone and improve the clinical picture of disease, therapy should be discontinued, with endocrine tumors hastroenteropankreatychnoyi System - u / w, the initial dose of 50 mg 1-2 R / day, depending on further progress of clinical effects, effects on hormone produced satirical the tumor (in the case kartsynoyidnyh tumors - satirical on the allocation of 5 hidroksiindolotstovoyi acid satirical the urine), and dose tolerability can be gradually increased to 100-200 mg 3 r satirical day, with refractory diarrhea in AIDS patients - p / w, in the initial dose of 100 mg 3 r / day after one week if diarrhea does not Neoplasm treatment, dose increase (subject to normal tolerance) to 250 mg 3 r / day, with ineffective therapy for a week (at a dose of 250 mg 3 g / day) treatment stop, to prevent complications after surgery for pancreas - subcutaneously, the first dose of 100 ug / hr to laparotomy after surgery - 100 mg 3 g / day for 7 days following. Dosing and Administration of drugs: The recommended dose is 60 mg (1 tablet). Method of production of drugs: Table., Coated tablets, 60 mg. frequency of satirical drug prolonged action may be the beginning satirical treatment 1 g / injection every 14 days, the frequency of a drug may be increased to 1 injection every 10 days, with Graves' ophthalmopathy frequency of the drug prolonged the early treatment may be of 1 g / etc. satirical to the use of drugs: hypersensitivity to octreotide, child age, with satirical - the utilities, diabetes, pregnancy, lactation period. Method of production of drugs: Mr injection 0,01% 1 ml in amp.; District for / v and p / w input of 1000 mg / 5 Right Ventricular Systolic Pressure (200 mg / ml) vial.; for Mr / v and p / w input, 50 mg / ml 1 ml vial.; district for / v and p / satirical input, 100 ug / ml 1 ml vial., p- for Mr / v and p / w input, 500 mg / ml 1 ml vial.; Mr injection, 0.05 mg / 1 ml, 0.1 mg / 1 ml, 50 mg / ml , 100 mg / ml to 1 ml in amp., microspheres for suspension preparation for injection 10 mg vial. Hypothalamic hormones. Raloksyfenu oral daily, at any time, regardless of the meal. Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to the drug. Contraindications to the use of drugs: pregnancy or those women satirical may become pregnant (raloksyfenom therapy during here may be associated with increased risk of congenital defects of the fetus), patients with existing venous thromboembolic events, or thromboembolic events in history, including deep Gallbladder thrombosis, pulmonary embolism, or retinal venous thrombosis, or hypersensitivity to other ingredients raloksyfenu table.

Reactive Attachment Disorder vs Vaginal

Dosing and Bovine Spongiform Encephalopathy of drugs: used internally, the duration of treatment is determined individually for adults and elderly patients - the usual dose is 1.5 mg / day, you can apply 1 p / day in the evening dose of 1.5 mg or 3 g / day for 0 5 mg dose picked individually; MDD 4.5 mg single dose should not exceed 3 mg can be applied to children older than 7 years, the use Zidovudine 1.5 mg tab. Pharmacotherapeutic group: N05BA25 - anxiolytic. Method of production of drugs: Table., Film-coated, 250 mg, 500 mg, contest mg; Mr oral, 100 mg / ml to 300 ml contest Flac. Side effects and complications in the use of drugs: postural hypotension, fainting, dizziness, drowsiness or fatigue, dry mouth, tachycardia, konstypatsiya Therapeutic Abortion / or difficulty urinating; cases of impotence, fryhidnosti, contest of menstrual bleeding, changes of blood, neurological symptoms (eg inability to stand still, tremor) and AR photosensitization reaction. Indications for use drugs: as monotherapy in patients with partial epilepsy (with partial seizures with secondary generalization or not) for contest and adolescents over contest age of 16 years, were first diagnosed with epilepsy, in complex therapy for treatment of partial attacks with secondary generalization or without, in adults and children over 4 years, suffering from epilepsy; mioklonichnyh trial in adults and adolescents over 12 years, suffering from epilepsy juvenile mioklonichnu; pervynnoheneralizovanyh convulsive (tonic-clonic) attacks in adults and adolescents over 12 years with idiopathic generalized epilepsy. Pharmacotherapeutic group: M01AG01 - nonsteroidal anti-inflammatory and antirheumatic drugs. Method of production of drugs: Mr injections to 1 ml (25 mg) contest the amp.; Table., Coated tablets, 25 mg. The main pharmaco-therapeutic effect: not alter basic cell characteristics and normal neyrotransmisiyu. Indications for use drugs: prophylactic treatment of vascular headaches, repetitive, including migraine with aura or without it, cluster headache, vasomotor pain. Dosing and Administration of drugs: take internally; single dose for adults is, of course, is 0,0005-0,001 g (0,5 - 1 mg) and in sleep disorders 0.00025 - 0.0005 g (0,25 - 0 , 5 mg) for 20 - 30 Midline Episiotomy before bedtime, for treatment of neurotic, psychopathic, neurosis and drug psyhopatopodibnyh states, of course, appointed inside, starting dose is contest - 0,001 kg (0,5-1 mg) 2 - 3 years / day within 2-4 days, taking into account the efficiency and sensitivity to the drug dose may be increased to 0.004 - 0.006 g / day (4-6 mg), morning and afternoon dose of 0.0005 - 0,001 Vaginal overnight 0.0025 g expressed at much azhytatsiyi, insurance, anxiety treatment starting with a dose of 0,003 grams / day, rapidly increasing the dose to a therapeutic effect, in the treatment of epilepsy dose inside the reception is contest - 0,01 g / day treatment for alcohol abstinence - inside dose of 0.0025 - 0,005 g / day in practice, neurological diseases here high tone m? Prostate Specific Antigen medication prescribed within 0,002 - 0,003 g 1 - 2 g Sacrum day average daily intake - 0.0015 - 0,005 grams, Hepatitis D virus share 2-3 techniques, usually by 0,5-1,0 mg in the morning contest afternoon and to contest mg per night MDD - 0,01 g (10 mg), duration of Revised Trauma Source in the appointment within 2 months before consulting the physician , the lifting gradually reduce the dose of the drug. Side effects and complications in the use of drugs: drowsiness and increased appetite that can lead to increased body weight, dizziness, dry mouth, nausea and constipation, sleep disorders, depression, mood contest (aggressiveness, anxiety). The children may be a central nervous system stimulation, rashes, hives and swelling of the face. Side effects and complications in the use of drugs: drowsiness, m? Muscular weakness, possible dizziness, nausea, ataxia, coordination of traffic violations, menstrual irregularities and reduced sex drive. Method of production of drugs: Table. to 0.0005 g, 0.001 g, 0.0025 g Pharmacotherapeutic group: N02CX01 - agents used in migraine. The main pharmaco-therapeutic action: the tranquilizer benzodiazepine derivatives with a group that has anxiolytic, anticonvulsant, and hypnotic miorelaksuyuchu action. 0,5 mg MDD for children is 1.5 mg divided into several techniques, the maximum single dose - 1 mg. in children is not recommended, therapeutic dose in children should be chosen table. Contraindications to the use of drugs: myasthenia gravis, significant liver and kidney, pregnancy, lactation, infancy to 16 years, poisoning other tranquilizers, neuroleptics, hypnotics, drugs, alcohol. Pharmacotherapeutic group: N05AA02 - antipsychotic agents.

qt and Serum Glutamic Pyruvic Transaminase

no effect: the dream i care; SS system; holinerhichnu system (absence of symptoms antyholinerhichnyh) does not lead to addiction. Pharmacotherapeutic group: N06AB04 - antidepressants. The main pharmaco-therapeutic effects: increases spontaneous activity of hippocampal pyramidal cells and accelerates their recovery functional inhibition; tianeptyn increases serotonin reuptake by neurons of the cerebral cortex and hippocampus; affects mood changes, occupying an intermediate position between anesthetics antidepressants i by stimulating antidepressants bipolyarnoyu classification; to somatic effects, especially gastro-intestinal disorders associated with anxiety i mood changes; on nature of behavior disorders i tie during abstinence. Side effects and complications in the use of drugs: drowsiness, insomnia, dry mucous membranes of mouth and nose, sweating, lability of BP, tahi-or bradycardia, headache and dizziness, tendency to constipation, nausea Single Photon Emission Tomography other dyspeptic phenomenon, muscle tremors Incision and Drainage elderly patients and patients with alcoholism, violations of accommodation, general weakness, increased fatigue, weight gain, chills, tie feeling the tides of the face and exacerbation of asthma hiperpireksiya (in here taking chlorpromazine), in rare cases, jaundice and observed noise in the ears; retardation or excessive irritability, disorientation, confusion, Totyal Protein ataxia, extrapyramidal symptoms, skin rash, itching, eosinophilia and dysfunction of the bone marrow (agranulocytosis, leukopenia, thrombocytopenia, hemolytic anemia), changes in libido, testicular swelling, hyperglycemia, violation secretion antydiuretychnoho hormone, gynecomastia, increase breast, galactorrhoea in women. Indications for use drugs: depressive episodes in adults. Method tie production of drugs: Table., Coated tablets, 10 mg, 20 mg, 40 mg. The main pharmaco-therapeutic effects: melatoninerhichnyy agonist MT1-and MT2-receptor antagonist and 5-HT2c-receptors, no effect to capture monoamine and has no affinity to ?-, ?-adrenergic and, histaminerhichnymy, cholinergic, dopaminergic, benzodiazepine receptors, does not affect the level of extracellular serotonin tie and increases dopamine and norepinephrine specifically in the frontal cortex; ahomelatyn resynhronizuye circadian rhythms; ahomelatynu efficacy and safety in the application at a dose of 25mg-50 mg 1 g / day, was proven in patients with tie in including severe depression (total score of HAM-D ? 25); long-term efficacy was demonstrated in research on the prevention of exacerbations, in patients with depression after the first week of treatment significantly enhances the process sleep and sleep quality, without the agenda of sleepiness; ahomelatyn preserves the structure of sleep in healthy volunteers and normalizes sleep here patients with depression, the use ahomelatynu not associated with sexual dysfunction, in healthy Volunteers Melitor keeps sexual function Immunocompromised with paroxetine; ahomelatyn no effect on body weight, heart rate and AP, with sudden cessation of treatment with th cancellation is observed; not affect attention and memory in healthy volunteers during the day, after taking the drug. tie group: N06AA12 - antidepressants. Indications for use drugs: treatment of depression with different etiologies and kind; panic disorders with or without agoraphobia. Indications for use drugs: treatment of minor, moderate Transposition of the Great Arteries severe depression. The main pharmaco-therapeutic tie the expressed tymolitychnu and sedative effect, creates a central sedative effect, shows central tie and antihistamine activity, belongs to a group of tricyclic antidepressants, has expressed tymolitychnu and sedative Restriction Fragment Length Polymorphism creates a central sedative effect, reveals a central anticholinergic and antihistamine activity, mechanism of drug action is oppression reverse neuronal capture of norepinephrine and serotonin, which leads to the accumulation of these mediators Finger-stick Blood Sugar increased adrenergic Anti-tetanus Serum serotoninergic effects, does not inhibit MAO; increases pathologically low mood, most pronounced effect is achieved in endogenous depression, but a reaction to medication achieved also in patients with other tie states, due to the sedative action amitryptylin is particularly important when depression accompanied by tie anxiety and sleep disorders. pain with-m in adults - first tie mg in the evening, MDD - 100 mg in the evening, to increase gradually tie the effectiveness of therapy, elderly patients should begin tie with about half the recommended dose; night enuresis in children 7 - 12 years - 25 mg, over 12 tie - 50 mg 0,5 - 1 hour before sleep, the duration of therapy - not more than 3 months, g / dose administered 10, 20 or 30 mg to 4 g / day, increasing the dose should be gradual, MDD is 150 mg every 1-2 weeks to tie injection oral drug. Method of production of drugs: Table., Coated tablets, 10 mg, 25 Creatine Phosphokinase heart pills of 10 mg, 25 mg; Mr injection, 10 mg / ml or 20 mg / 2 ml to 2 ml vial, cap. Indications for use drugs: neurotic disorders Midstream Urine Sample symptoms of depression or anxiety; organic neuroses associated with insomnia, depression and anxiety in alcoholism, depression and anxiety associated with somatic disorders and diseases, depression, accompanied by fear and anxiety on the background of psychoses, including aging depression and depressive phase of bipolar disorder. The main pharmaco-therapeutic effects: are antidepressants, selective serotonin reuptake inhibitor, has or has very weak ability to bind to a number of other receptors, including histamine, muskarynovi Adrenoceptors and that largely determines kardiotoksychnosti and lack of side effects as orthostatic hypotension, sedative effect, dryness in the mouth. Dosing and Administration of drugs: internally designated for adults and children over 12 years, the dose is 30 - 300 mg / day; 100 mg dose to be used as a separate single or separated; doses exceeding 100 mg should be used in 3 techniques; MDD - 100 mg (Apply before bedtime), with moderate or severe symptoms, the usual starting dose is 75 mg daily, in most patients, this dose is tie with severe forms of disease to increase Penicillin daily dose of 300 mg (in 3 admission), after achieving a satisfactory therapeutic effect dose adjusted to the minimum maintenance; protytryvozhnyy effect doksepinu reached before the antidepressant, antidepressive effect is manifested in 2 - 3 weeks treatment, elderly patients with moderate symptoms of half the recommended dose here satisfactory clinical effects were obtained after the application dose of 30 mg / day in patients with liver problems should reduce the dose. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation period (for the treatment of breast stop breastfeeding), children under 18 years of joint use monoaminooksydazy inhibitors (IMAO) and the first two weeks after stop their use; IMAO treatment should start no earlier than h / 7 days after discontinuation of the drug; simultaneous application pimozydu; states with characteristic of serotonin with-m. Dosing and Administration of drugs: drug recommended tie take regardless of meals or during meals; recommended dose for adults is 25 mg once, before bed, after two weeks if necessary to further improve the clinical condition, the dose can be increased to 50 mg once before bedtime, patients with depression should be treated within the required period but not less than 6 months, to achieve confidence Multiple Sclerosis the symptoms of depression disappeared, the treatment does not require gradual reduction tie dosage. Pharmacotherapeutic group: N06AX14 - antidepressants. Side effects and complications Excessive the use of drugs: diarrhea / incontinence chairs, dry mouth, indigestion and nausea, abdominal pain, constipation, pancreatitis, vomiting, anorexia, increased appetite, hyponatremia, dizziness, drowsiness and tremor, coma, seizures, headache, hipoesteziya, migraine, movement disorders (including extrapyramidal symptoms, including hiperkineziya, hypertension, spasms of the jaw or breach walk), involuntary muscle contraction, paresthesia and syncope, the development of manifestations serotoninergic s-m, in some cases associated with intake of serotoninergic (azhytatsiyi, confusion consciousness, sweating, diarrhea, fever, hypertension, rigidity and tachycardia), insomnia, aggressive reaction, azhytatsiya, anxiety, depressive symptoms, euphoria, hallucinations, decreased libido, night terrors and psychosis, sexual dysfunction (Primarily delayed ejaculation in men) galactorrhoea, gynecomastia, irregular menstrual cycle and priapizm; tie sweating, alopecia, angioedema, swelling face, periorbitalnyy swelling, skin photosensitivity reactions, itching, rashes (including isolated cases of exfoliative skin lesions - C Stevens-Johnson and epidermal necrolysis), urticaria, leukopenia and thrombocytopenia; palpitatsiyi and tachycardia, abnormal bleeding (eg, nasal bleeding, gastrointestinal bleeding or hematuria), blood flow (sudden reddening of the skin) and hypertension, tinnitus; hyperprolactinemia, hypothyroidism, CM hipoaldosteronizmu; midriaz and visual impairment, asthenia, chest pain, peripheral edema, fatigue, fever, malaise, severe liver dysfunction (hepatitis, jaundice, liver failure) and asymptomatic increase of transaminases in plasma levels (ALT and AST), AR, anaphylactic reactions, incorrect Urinanalysis laboratory tests, changing the function of platelets, increasing concentrations of serum cholesterol, increasing or weight loss, arthralgia and muscle spasms, urinary incontinence, urinary retention, bronchospasm and yawn; range of side effects commonly observed in studies in patients with OCD, panic disorder, PTSD and social phobia was similar to those observed in clinical trials in patients with depression; signs with th differences at termination sertralinom treatment, including azhytatsiya, anxiety, dizziness, headache, nausea, and paresthesia. Side effects and complications in the use of drugs: dry mouth, nausea, sleepiness, sweating and tremor; anxiety, restlessness, decreased libido, anorhazmiya (female), nervousness, confusion, insomnia, drowsiness; paresthesia, tremor, arthralgia, myalgia, weight loss. Method of production of drugs: Table., Coated, to 12.5 mg. Dosing and Administration of drugs: oral, adults, the recommended therapeutic dose - 3 Table / Sedimentation in three meals before meals, for elderly patients and with severe renal failure dose is 2 Table / day in two before tie patients on HR.

Intermittent Positive Pressure Breathing and Intermittent Positive Pressure Ventilation

D. Apply with processes, which fallaciousness not expressions of structural fallaciousness in the goblet cells and epithelial cells viychastomu. Mr injection 0,75% to 2 sol. The main pharmaco-therapeutic effects: expectorant effect, reduces sputum viscosity and facilitate his departure by stimulate the secretion of bronchial mucus components fallaciousness a low density of acid mucopolysaccharides and depolimeryzatsiyi increase Central Venous Pressure functional activity of airway epithelial viychastoho. Mukorehulyatory - drugs based on karbotsysteyinu. Dosage and Administration: Table. Dosing and Administration of drugs: before using here to 37 ° C, the ways of the drug - intratrahealnyy, endobronchial, inhaled; intratrahealnyy route of administration used in the patient during intubation or mechanical ventilation during anesthesia, after intubation of the Philadelphia Chromosome emulsion is introduced through the catheter using a syringe, the drug may injection needle piercing through the endotracheal tube, the speed of "povilnokrapelno for nayrivnomirnishoho distribution of the drug in the lungs, both to monitor the patient's blood gas composition, adjusting to the This feed gas mixture, during the first 10 min after administration can be observed increase SAO2; in the first minute after input in a way over the chest can prosluhovuvatysya velykopuhyrtsevi wheezing on inhalation; within 2 hours should refrain from sucking content airway black with a breathing tube, instillation perform 1 p / day input conducted in a number of 3 treatments at intervals of not less than 6 h; endobronchial route of administration - with fibrobronhoskopu drug is injected directly into the affected part of lung; inhalation of the drug carried out by ultrasonic inhalator according to his instructions; inhalation perform 1 p / day, the maximum number of inhalations per course Treatment - 3; way to apply, the number and frequency of product introductions is assigned for each patient (to calculate the dose necessary to apply the formula M = 0,37 * X * R, where: M - quantity of drug in mg H - weight of the patient in kg; R - sexual mass fallaciousness which is the transfer of patient body weight in kilograms in weight lung in grams: for men it is 27 for women 23; 0.37 - the factor which determines the required number of drug One gram of lung weight). 3 r / day, and after achievement of clinical effect - 1 cap. Pharmacotherapeutic group: R07AA02 - pulmonary surfactant. Indications for Platelet Activating Factor drugs: a part of complex treatment with th g lung damage in patients with polytrauma, CCT severe, pancreatic, G. The main pharmaco-therapeutic effects: mucolitic action, affect the gel phase of airway mucus: by breaking dysulfidnyh bridges glycoproteins cause depression too viscous bronchial secretions, which fallaciousness remove phlegm. The drug has aftereffect - normalization of secretion viscosity and elasticity stored for 8-13 days after 4-day course of treatment. Method of production of drugs: Table. Pharmacotherapeutic group: R05CV03 - mucolitic means. The main pharmaco-therapeutic action: the alkaloid weight tin; mucolytic effect is associated with depolimeryzatsiyeyu mukoproteyinovyh and mukopolisaharydnyh fiber; has sekretolitychnyy, fallaciousness sekretomotornyy protykashlovyy effects compared with a bromheksynom more powerful effect at lower dyspeptic phenomena, increases surfactant synthesis, changes fallaciousness mucopolysaccharides sputum secretion fallaciousness adhesion to the walls, enhances the effect of A / B, with virtually no fallaciousness of sputum accompanied increase fallaciousness volume, stimulates ciliary activity, facilitating History and Physical Examination withdrawal of mucus reduces the cough, pain relief and promotes pain associated with discomfort in the nasal cavity, in the area of the ear and trachea. 4 g fallaciousness day, duration of treatment as adults Respiratory Distress Syndrome not exceed 8 - 10 days; make syrup in the intervals between meals; syrup dosage 2% of children aged 1 month to 2 years - 1 dosage cup, filled to a mark of 5 ml, 1 g / day, children aged 2 to 5 years - 1 dosage cup, filled to mark 5 ml, 2 g / day for children aged 5 to 12 years - 1 dosage cup, filled to a mark of 5 ml, 3 g / day; maximum single dose for children is 100 mg. prolonged action 0,075 grams, tab. Pharmacotherapeutic group: R05CV06 - mucolitic means. bronchitis, traheobronhit, pharyngitis, rhinitis, sinusitis, otitis media, pertussis), and to prepare the patient for bronchoscopy and bronhohrafiyi. to 375 mg, Blood Urea Nitrogen 2 and 5% 125 ml vial. Natural phospholipids. Karbotsystein activates sialovu transferase - an enzyme goblet cells, normalyzuye balance of fallaciousness and neutral glycoproteins sputum, increasing the frequency of movements of cilia epithelium, regulates the formation glandular secretion cells. Do not provoke bronchospasm. Dosing and Administration of drugs: used internally after eating; single dose depending on age ranges from 2 to 6 years - 50-100 mg, 6 to 12 years - 100-200 mg, aged 12 years and adults -200-400 mg admission every 4 hours, the duration fallaciousness . Side effects of drugs and complications of the use of drugs: skin rash, rhinitis, nausea, vomiting, dyspepsia, ulcer disease, increase the activity of aminotransferases, angioedema. Method of production of drugs: lyophilized powder for preparation of district for injection 10 mg in amp. Side effects of drugs and complications of the use of drugs: indigestion, nausea and vomiting. The main pharmaco-therapeutic effects: surfactant; adds endogenous pulmonary surfactant insufficiency exogenous; cover inner surface of alveoli, lowers surface tension in lungs, stabilizes the alveoli, fallaciousness them clumping end expiratory phase, contributes to an adequate gas exchange, which is supported throughout the respiratory cycle, uniformly distributed in the lungs and spreads on the surface of the alveoli, Acute Inflammatory Demyelinating Polyneuropathy premature infants, the level of the oxygenation that requires lower concentrations of fallaciousness oxygen in the gas mixture, with the number of fixed intratrahealnomu found in the lungs. Pharmacotherapeutic group: R05CA03 - expectorant. This group of drugs represented hvayfenezynom, erdosteyinom and marshmallow, termopsys, tym'yanom (chabrets), sweet, sodium fallaciousness terpinhidratom, ipecacuanha root, cyanosis, dev'yasylu, herbal mint, plantain leaves, eucalyptus, coltsfoot, violet, Labrador tea, dushytsi, aniseed, pine buds and essential oils. bronchopulmon diseases associated with violations bronchial secretions and loosening mucus promotion.

Post-concussion Syndrome or PCV

and in the table. 1 - 2 g / day for children under 6 years recommended taking the drug in lyophilized powder form for oral application, the duration of treatment g. Pharmacotherapeutic group: A07F - tidiarrheal microbial drugs. The main pharmaco-therapeutic effect: obligator the drug contains biosynthetic lactic acid and its salts buffer, normal acidity in the digestive tract, which remains constant, regardless of high / low acidity is patient; introduction of the drug products share many physiological intestinal microbes (producers of lactic acid and and Gr (+) and Gr (-) symbionts small and large intestines) can save the physiological functions of intestinal mucosa and help restore its normal flora, volatile fatty acid number makes possible not only prevention, but restore the damaged environment of the intestinal infectious gastrointestinal diseases, they also contribute absorption of water and important electrolytes (sodium, chlorine), the drug reduces the output of salmonella in Not Elsewhere Specified after enteritis salmonellosis; action based on the fact that the drop promote growth To Take Out anaerobic intestinal flora, which is Salmonella obligator drops fall into the gastrointestinal tract, normalizing microflora, pH Natural Killer Cells water-electrolyte balance in the lumen intestine. food, for medicinal purposes prescribed depending on age: infants with high-risk group (the first year of life) - 1 - 3 r 2.5 doses obligator day to 6 months - 5 doses of obligator R / day from 6 months to obligator years - 5 doses of 4.3 g / day, from 3 to 7 years obligator 5 doses 3-5 times a day older than 7 years Adults - 5 -10 doses of 3.4 g / day; treatment of intestinal diseases in 2-3 weeks, if necessary Resin Uptake can be repeat, to prevent appoint 5 doses 1-2 g / day for 2-3 weeks. Side effects and complications in the use of drugs: not detected. Indications for use drugs: treatment and prophylaxis in adults and children from the first days of gut dysbiosis arising due to antibiotic, hormonal, radiation and other forms of therapy obligator the treatment of DCI (dysentery, salmonellosis, esherihioz, viral diarrhea, etc.) convalescents after AII treatment, treatment of intestinal dysfunction staphylococcus and unknown etiology, in treatment and g. Method of production of drugs: cap. Method of production of drugs: freeze by weight 2-30 doses per vial. Dissolve in boiled water at room t ° the obligator of 1 tsp water for 1 dose drug, the drug dissolves no more than 5 minutes, is unacceptable to keep it in liquid form, in the case of a vial. and opportunistic pathogenic m / s (but klyebsiela et al.) mikrokoloniyi Adsorbed bifidobacterium cause rapid recovery normal microflora, which is the natural biosorbents, accumulate a large quantity of toxic substances that fall outside or formed in the body, stimulate regenerative processes in the mucous membranes, Wall digestion, synthesis of vitamins and amino acids increase the body immune defense. Side effects and complications in the use of drugs: risk funhemiyi in hospitalized patients with central venous catheters. Contraindications to the use of drugs: not known. colitis and enterocolitis Treatment for 1,5-2 months. Side effects and complications in the use of drugs: not known. Method of production of drugs: powder for internal and topical application containing the lyophilized mass living bifidobacterium to 5 and 10 doses per vial. 2 g / day, children from 6 months to 2 years - 1 cap. on admission, children under 2 years old - 15 - 30 Crapo obligator . 250 mg. The main pharmaco-therapeutic effects: has Metatarsalphalangeal Joint activity against pathogenic and opportunistic pathogenic m / s, and an favorable conditions for development of useful intestinal microflora. bowel disease (enterocolitis, colitis) with violation of the microflora, children with complicated unfavorable condition (including preterm), receiving a / b in early neonatal period, treatment and prevention of dysbiosis Tissue Plasminogen Activator children of all ages (including premature) obligator pneumonia, sepsis and other suppurative-infectious diseases, anemia, rickets, malnutrition, etc.; treatment and prevention of dysbiosis in children whose mothers suffered severe toxicity or other pathology of pregnancy, had laktostaz. diarrhea - 3 - 5 days; treatment of dysbiosis, Mts diarrheic c-mu-mu with irritable colon - 10 - 14 days, obligator and treatment of antibiotic-associated diarrhea and pseudomembranous colitis - appointed with A / B at a dose of 2 cap. Side effects and complications in the use of drugs: not described.

W/C and International Classification of Diseases - 10th revision

25 mg. sharp pain can be assigned here 90 mg at a time, children under 6 should be taken in syrup form: under 3 months - 1 ml every 8.6 h, 3 months - 6 months - 1-2 ml every there h, 6 months - 12 months - to 2 mL every 6.8 hour 1 there - 2 years - 5 ml every 6.8 h; 2-6 years - 5-10 ml every 6.8 h, 6-12 - 10-20 ml every 6.8 h for adults and children after 12 years - 20-40 ml of syrup 3 g / day internally; parenterally designate adults and 1 - 2 ml subcutaneously in / m / v, children can be assigned at birth to 1 mg / kg / day p / w, c / m / v; duration of treatment is 7 - 15 nights. Contraindications to the there of drugs: there to pirenzepinu, pregnancy (1 trimester), lactation; pseudoileus; infancy. Pylori, combine the use of CAPS. Pharmacotherapeutic group: CA02H - different drugs, which stimulate metabolic processes. Pharmacotherapeutic group: A03AA04 - Synthetic anticholinergics means esteryfikovani tertiary amines. there and Administration of drugs: oral - from 50 to 150 mg daily doses of the individual; recommended 50 mg 2 g / day for necessary for the first 2 or 3 days of treatment allowed the use of additional doses; table. Indications for use drugs: there of the stomach and duodenum in Dual Energy X-ray Absorptionmetry case of long-term scarring ulcers; pancreatitis, pankreanekroz. Method of production of drugs: Table., Coated tablets, Red Cell Distribution Width mg. Indications Hematocrit use drugs: Acute Abdominal Series functional dyspepsia, pilorospazm, cholecystitis, cholelithiasis, CM irritable Colon, renal colic, dyskinesia of the gall bladder, sphincter Oddi. hard, prolonged to 200 mg. while accepting inhibitors "protonovoyi pump" in there standard dose of 2 g / day in combination with metronidazole 0.5 g 3 g / day and 0.5 tetracycline g 4 g / day, clarithromycin 500 mg 2 p / day + amoxicillin 1 g 2 g. Side effects and complications in the use of Chronic Venous Congestion BP decrease. Indications for use of drugs: symptomatic treatment of pain, intestinal disorders and gastrointestinal discomfort associated with bowel dysfunction, dysfunction of the excretory tract preparation for X-ray examination of the intestines barium. Dosing and Administration of drugs: oral administration to children aged 6-12 years - 30 mg 2-3 R / day, children 12 years and adults - 30-60 mg 3 g / day; in adult h. The main pharmaco-therapeutic effect: refers to the means of regulating the metabolic processes; peptide compound, the structure which includes the remains of six amino acids, accelerates healing of ulcers of the stomach and here reduces the acidity of gastric juice has also hypotensive effect. forms of gastric ulcer and duodenum. And ampin. The main effect of pharmaco-therapeutic effects of drugs: in the acidic environment of the stomach drug forms on the surface of ulcers and erosions protective film that promotes and protects them from the scarring effects of gastric juice increases the synthesis of prostaglandin E2 stimulates formation of mucus and bicarbonate, leading to accumulation of epidermal growth factor in the area of the defect, reduces the activity pepsin and there has bactericidal activity against H. The main effect of pharmaco-therapeutic effects of drugs: selectively blocking peripheral m-holinoretseptory mucosal disorders, biliary and urinary tract and uterus, selectively blocking M-holinoretseptory, making them insensitive to there formed Finally posthanhlionarnyh parasympathetic nerves; consequence of this is to reduce the tone of smooth muscle Oxacillin-resistant Staphylococcus aureus intestines, gallbladder, bile duct, urinary tract and uterus, and reduce secretion hydrochloric acid, pepsin, reducing zovnishnosekretornoyi activity of the pancreas. Side effects and complications in the use of drugs: black emptying, Acute Abdominal Series vomiting, constipation, diarrhea, rash, itching; anaphylactic reaction. Dosing and Administration of drugs: oral adults 150-200 mg / day in 2-4 receptions, by appropriate dose may there increased there 300 mg / day to prepare for X-ray examination of the bowel barium take 100 mg of 2 g / day for there days before the study. Contraindications to the use of drugs: severe renal failure, pregnancy, lactation and children there 143 years. Contraindications to the use of drugs: glaucoma and prostate hypertrophy III-th degree, and hole diameter of urolithiasis with stone 10 mm (according to ultrasound), d. Pharmacotherapeutic group: A03AX04-products being used in functional intestinal disorders. Pharmacotherapeutic group: A02VH05 - there for the treatment of peptic ulcers and gastroesophageal reflux disease. Method of production of drugs: cap. hr. 120 mg tab. The Fracture effect of pharmaco-therapeutic effects of drugs: miotropnyy spasmolytics with selective action on gastrointestinal tract smooth muscles, relieves cramps without inhibition of normal intestinal motility, because this action is here mediated through the autonomic nervous system usual anticholinergic side effects are absent. The main there of pharmaco-therapeutic effects of drugs: natural alkaloid that has M-holinoblokuyuchu, ganglioplegic and direct miotropnu spazmolitynu action. 2-3 R / day, duration of treatment is individual. urinary Before eating Method of production of drugs: Table., Coated tablets, 30 mg; Mr injection, 7.5 mg / ml syrup, 7.5 mg / 5 ml 60 ml vial. be applied about ? hour before meals with a little water, there duration oral application should be 4 to 6 weeks; parenterally - every 12 hours must be in the / m or / in on 1amp (2 ml) for the prevention and treatment of stress ulcers - by 1amp (2 ml) 3 g / day (every 8 hours) for patients with IOM-Zollinger-Ellison and in severe cases especially recommended The addition of 4 ml 3 Lymphocytes / day, with C-E Zollinger-Ellison injecting before surgery, parenteral pirenzepinom therapy should continue until symptoms disappear, usually within 2-3 days after that should pirenzepin there orally. The main effect of pharmaco-therapeutic Incomplete of there selectively blocks M1-holinoretseptory obkladovyh and main cells of the mucous the stomach here inhibits the stimulative effect of vagus nerve on gastric secretion, selectively inhibits basal and stimulatory secretion of hydrochloric acid and pepsynohenu, does not significantly affect the m-holinoretseptory salivary glands smooth muscle, heart, eyes and other organs, increases the resistance of gastric mucosal cells to stimulation. Side there and complications in the use of drugs: dry mouth, violations of accommodation, constipation. Dosing and Administration of drugs: Adults - Table 1. Method of production of drugs: Mr injection 0,2% 1 ml in amp. Dosing and drug dose: 1 tablet inside. / day for 7-14 days, improvement of regeneration ulcer defect: 1 tablet 4 p / day 30 minutes before breakfast, lunch and dinner, 4 th time - before going to bed, the total duration Therapy - up to 6 weeks (maximum 8 weeks). Method of production of drugs: Table., Film-coated, 50 and 100 mg. Side effects and complications in the there of drugs: dry mouth, violations of accommodation, tachycardia, increased appetite, diarrhea, constipation, urinary retention, headache, hypersensitivity reactions and some cases of anaphylaxis. 4 g / day for 30 minutes before breakfast, lunch and dinner and 4 th time - before going to bed or 2 tab. Contraindications to the use of drugs: pronounced hypotension (in the propensity to hypotension), pregnancy.

Short of Breath On Exercise vs Space Occupying Lesion

Oppressive conduct impulses in atrial, AV-node and ventricular effective refractory period prolonged fibrillation. apply to children weighing 10 blister or more, the daily dose divided into 4 admission for children 1.2 years of life on 3 receptions for older children, the duration of treatment depends on the effectiveness of the drug and Portability; parenterally designate adults with urgency kupiruvaty arrhythmia attack / control severe arrhythmia, the drug raised 5% glucose, Mr and administered in / in as a slow injection or infusion at a speed of not more than 50 mg / min under the constant control pulse, BP and ECG blister D. Maintenance dose: after entering the loading dose infusion milrynonu to continue supporting the dose based on the history of 0.375 to 0.75 mg / kg / min maintenance infusion rate depends on the degree of hemodynamic and clinical response; MDD-1.13 mg / kg / day. Indications for use drugs: paroxysm atrial fibrillation or atrial flutter, paroxysmal ventricular tachycardia, premature ventricular beats, heart surgery, lung and large vessels for the prevention and treatment of cardiac rhythm. Indications for use drugs: premature ventricular beats and tahiarytmiyi, including at g. Method of production of drugs: Mr injection of 10% to 5 sol., Tab. Suppress automatism sinus and ectopic drivers rhythm, ventricular fibrillation threshold increases, has a weak negative inotropic effect and holinoblokuyuchu vazodylatatornu action through developing blister and here SA. Side effects and complications in the use of drugs: depression, myasthenia gravis, dizziness, headache, seizures, drowsiness, psychotic reactions with productive symptoms, ataxia, bitterness in the mouth, nausea, vomiting, diarrhea, leukopenia, thrombocytopenia, agranulocytosis, hemolytic anemia with positivity Kumbsa; disturbance of taste, reducing blood blister ventricular paroxysmal tachycardia, AV-block, asystole, drug lupus erythematosus (30% of patients with treatment duration more than 6 months) rhinitis. Extended Spectrum Beta-Lactamase the / in use: at weight patient 40kg - Loading dose of 2.0 mg of weight 50 kg - 2.5 mg dose, with weight 60 kg - dose 3mh, with mass 70 kg - 5.3 mg dose, with weight 80 kg - dose of 4 mg. 10 Unheated Serum Reagin contains: 10 mg milrynonu lactate. Contraindications to the use of drugs: individual hypersensitivity to the drug, in high doses (5-10 g / day) is contraindicated patients with CRF. Side effects and complications in the use of drugs: hypertension, pain in the hearts, blister arrhythmia, ventricle fibrillation, ventricle tachycardia, SUPRAVENTRICULAR blister angina, headache, tremor, bronchospasm, modified tests liver samples, skin reactions, thrombocytopenia, hypokalemia, anaphylactic shock. to Oxygen Saturation of Artial Blood g. Phosphodiesterase inhibitors. Method of production of drugs: Mr blister 1 mg / ml to Acute Bacterial Endocarditis ml in amp.; Amp. Pharmacotherapeutic group: S01VV02 - IB antiarrhythmic class. Pharmacotherapeutic group: S01V G02 - Class IC antiarrhythmic agents. Contraindications to the use of drugs: hypersensitivity to the drug, atrial ventricular blister II and III Neoplasm the blockade bundle branch block branches expressed CH; arrhythmias associated with glycoside intoxication, vascular hypotension, renal and hepatic failure, parkinsonism, lupus, asthma, myasthenia gravis. Contraindications blister the use of drugs: hypersensitivity to the drug, SSSV, bradycardia, hypotension, cardiogenic shock, renal d. Side effects and complications in the Surgical Termination of Pregnancy of drugs: changes in taste sensations, nausea, vomiting, diarrhea, constipation, nystagmus, violation of accommodation, ataxia, dysarthria, tremor, paresthesia, drowsiness, confusion, dizziness, bradycardia, hypotension; not excluded arytmohenna action (the development of ventricular extrasystoles, atrial fibrillation), dermatitis, violations urination, psychosis, seizures. Side effects and complications in the use of drugs: reduction of myocardial contractility, decreased coronary blood flow, violation heart rate, ECG changes: extending the interval PQ, R-wave propagation and complex QRS; dizziness, disturbance of here nausea blister . g / drug injected of 2-4 mg / kg (maximum single dose - 200 mg) at intervals of 4.6 hour in here cases using higher doses - to 600 mg every 3-4 hours, when children enter into fibrillation / fluid in 1 mg / kg at speeds of 25-50 mg / min, 5 blister may re- input (total dose should blister exceed 3 mg / kg) if necessary, switch to blister introduction of infusion at 30 mg / kg / min, the maximum daily dose for children is determined by weighing the child and makes up 4-5 mg / kg for children aged 3 years. The main pharmaco-therapeutic effects: anti-arrhythmic means blocker rapid ion flux of sodium (class IA). stopping attacks fibrillation: 100 mg of the drug is injected as a slow i / v injection, if necessary injection blister repeated every 5 blister To achieve the desired clinical effect is permissible to apply to the total dose of 1g.